| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/19/2006 | EP1646632A2 Substituted tetrahydro-1 i h /i -pyrazolo 3,4-c|pyridines, compositions containing same and use |
| 04/19/2006 | EP1646401A2 Specific human antibodies |
| 04/19/2006 | EP1646385A2 Use of benzothiopenes to treat and prevent prostate cancer |
| 04/19/2006 | EP1646382A2 Compounds, compositions and methods |
| 04/19/2006 | EP1646380A2 Indolocarbazole anticancer agents and methods of using same |
| 04/19/2006 | EP1562573B1 Pharmaceutical pellets comprising tamsulosin and a process for making the same |
| 04/19/2006 | EP1537112B1 Condensed pyridines and pyrimidines with tie2 (tek) activity |
| 04/19/2006 | EP1513833B1 Novel 3-(4-oxo-4h-chromen-2-yl)-(1h)-quinoline-4-one derivatives, method for preparing same and pharmaceutical compositions containing same |
| 04/19/2006 | EP1463730B1 Pyrazolopyridazine derivatives |
| 04/19/2006 | EP1448564B1 Substituted indolizine-like compounds and methods of use |
| 04/19/2006 | EP1387838B1 Cyanoanthranilamide derivatives and the use thereof as medicaments |
| 04/19/2006 | EP1365777B1 Compositions comprising proteoglycan and their use for the treatment of inflammatory conditions |
| 04/19/2006 | EP1353921B1 Tetrahydropyridine derivatives, their preparation and their use as cell proliferation inhibitors |
| 04/19/2006 | EP1349833B1 Indole and dihydroindole derivatives |
| 04/19/2006 | EP1339695B1 Farnesyltransferase inhibitors |
| 04/19/2006 | EP1317428B1 Pyrrolidine-2-carboxylic acid hydrazide derivatives for use as metalloprotease inhibitors |
| 04/19/2006 | EP1296959B1 Methods and compositions utilizing quinazolinones |
| 04/19/2006 | EP1294724B1 Pyrrolo¬2,3-d|pyrimidine compounds as immunosuppressive agents |
| 04/19/2006 | EP1292290B1 Pharmaceutical compositions comprising acryloyl distamycin derivatives and topoisomerase i and ii inhibitors |
| 04/19/2006 | EP1259125B1 Inulin products with improved nutritional properties |
| 04/19/2006 | EP1255537B1 Farnesyl protein transferase inhibitors for treating breast cancer |
| 04/19/2006 | EP1212330B1 Androgen receptor modulator compounds and methods |
| 04/19/2006 | EP1204650B1 Substituted 2-arylbenzazole compounds and their use as antitumour agents |
| 04/19/2006 | EP1121381B1 Zinc finger binding domains for gnn |
| 04/19/2006 | EP1112284B1 Piperazine-4-phenyl derivatives as inhibitors of the interaction between mdm2 and p53 |
| 04/19/2006 | EP1080726B1 Agents for relieving side effects |
| 04/19/2006 | EP1051177B1 Steroid 3-o-sulphamate derivatives as inhibitors of oestrone sulphatase |
| 04/19/2006 | EP1044197B1 Piperidinyl-substituted pyridylalkane, alkene and alkyne carboxamides as cytostatic agents and immunosuppressants |
| 04/19/2006 | EP0930877B1 D-methionine to reduce the toxicity of platinum-containing anti-tumor compounds |
| 04/19/2006 | EP0873355B1 Tethered prodrugs by virtue of covalent linkage with analogs of glutathione |
| 04/19/2006 | EP0789574B1 Use of naked polynucleotides in the manufacture of a medicament for treating tumours |
| 04/19/2006 | CN1761686A Proteoglycan isolated from cartilaginous fish and process for producing the same |
| 04/19/2006 | CN1761683A Cancerous disease modifying antibodies |
| 04/19/2006 | CN1761681A Regulation of gene expression |
| 04/19/2006 | CN1761680A Metastin derivative and use thereof |
| 04/19/2006 | CN1761671A 4-aminothieno [2,3-d] pyrimidine-6-carbonitrile derivatives as PDE7 inhibitors |
| 04/19/2006 | CN1761668A 7-imino derivatives of camptothecin having antitumor activity |
| 04/19/2006 | CN1761666A Polyhydroxylated pyrrolizidine |
| 04/19/2006 | CN1761485A Micellar preparation containing sparingly water-soluble anticancer agent and novel block copolymer |
| 04/19/2006 | CN1761484A A method of diagnosis and treatment |
| 04/19/2006 | CN1761480A APLIDINE for multiple myeloma treatment |
| 04/19/2006 | CN1760362A Gene clone and expression of RGD die body protein of oral gland in Japan lamprey possessing function for anti tumour |
| 04/19/2006 | CN1760208A Iluman wild type P53 fusion protein |
| 04/19/2006 | CN1760202A Anticancer new compound of Xiacaogan I, preparation method, and application in pharmacy |
| 04/19/2006 | CN1760166A New method for picking-up purified resveratrol from giant knotweed |
| 04/19/2006 | CN1759881A Medicine of Fufang Luxiancao for treating liver cancer |
| 04/19/2006 | CN1759862A Prescription of arenobufagin drop pills and preparation method |
| 04/19/2006 | CN1252260C Tumor-specific promoters |
| 04/19/2006 | CN1252089C Construction and preparation of stroma cell derivative factor ¿C 1alpha recombinant mutant |
| 04/19/2006 | CN1252079C Novel substance having physiological activity, process for producing the same, and use |
| 04/19/2006 | CN1252078C Method for extracting total aglycone of Macrotys and its antitumour action |
| 04/19/2006 | CN1252075C Complex ML(DCA) of copper(óÄ), gallium(ó¾) and rare earth ion(Ln**) containing non-methyl canthridic acid radical |
| 04/19/2006 | CN1252071C Xanthine Phosphodiesterase V inhibitors |
| 04/19/2006 | CN1252070C Urea substituted imidazoquinolines |
| 04/19/2006 | CN1252069C 2-aryl-naphthyridin-4-ones as antitumor agent |
| 04/19/2006 | CN1252067C Benzazole derivatives and their use as JNK modulators |
| 04/19/2006 | CN1252065C Cinnoline compounds |
| 04/19/2006 | CN1252040C Novel aryl, alkenyl and alkynl 4-dedimethylamino tetracycline derivatives |
| 04/19/2006 | CN1251767C Kit for radiolabeling proteins with yttrium-90 |
| 04/19/2006 | CN1251766C 肿瘤基因开关药物 Tumor gene switch drugs |
| 04/19/2006 | CN1251765C 肿瘤基因开关药物 Tumor gene switch drugs |
| 04/19/2006 | CN1251764C 肿瘤基因开关药物 Tumor gene switch drugs |
| 04/19/2006 | CN1251761C Vaccine comprising cytokine-induced heat shock proteins |
| 04/19/2006 | CN1251756C Series Chinese medicinal composition for treating liver cancer, esophagus cancer and gastric cancer |
| 04/19/2006 | CN1251707C Application of Engally nut oil in the preparation of medicine for treating arthritis |
| 04/19/2006 | CN1251700C Application of flatstem milkvetch seed and its extract in the preparation of anti hepatic fibrosis medicine and anticancer medicine |
| 04/19/2006 | CN1251688C Freeze dried arsenic trioxide injection and its preparation process |
| 04/19/2006 | CN1251680C Compositions comprising cytosine derivatives for the treatment of cancer |
| 04/19/2006 | CN1251677C Anti-cancer assistant medicine contg. 20(S)-protopanaxadiol as effective component, and its application |
| 04/19/2006 | CN1251676C Phenyl xanthine derivative |
| 04/18/2006 | US7030242 Selective inhibition of aggrecanase in osteoarthritis treatment |
| 04/18/2006 | US7030219 Nucleotide sequences coding protein for use in treatment of cancer and prevention of viral infection |
| 04/18/2006 | US7030211 Antigenic peptides derived from telomerase |
| 04/18/2006 | US7030147 Synergistic mixture; antiproliferative agents; side effect reduction |
| 04/18/2006 | US7030141 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade |
| 04/18/2006 | US7030132 An inhibitor of breast cancer resistance protein (BCRP) is orally administered concomitantly with a pharmaceutical compound. |
| 04/18/2006 | US7030131 such as N-[4-(4-amino-1H-imidazol[4,5-c]quinolin-1-yl)butyl]-5-(dimethylamino)-naphthalenesulfonamide; for induction of biosynthesis of cytokines; immunomodulators; antineoplastic agents |
| 04/18/2006 | US7030125 useful in the treatment of TGF- beta related disease states including, for example, cancer and fibrotic diseases |
| 04/18/2006 | US7030123 Indole derivatives with vascular damaging activity |
| 04/18/2006 | US7030118 Pyrrolotriazinone compounds and their use to treat diseases |
| 04/18/2006 | US7030112 Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders |
| 04/18/2006 | US7030111 drugs such as 4-chloro-benzoic acid p-tolyl ester, used to control or suppress the onset of mitosis until DNA replication and repair are complete; prophylaxis of proliferative disorders |
| 04/18/2006 | US7030099 Tumor specific promoters of the midkine gene that allow for selective expression in P53-inactivated cells |
| 04/18/2006 | US7030090 Immune-modulating peptide |
| 04/18/2006 | US7030089 Use of substituted acryloyl distamycin derivatives in the treatment of tumors associated with high levels of glutathione |
| 04/18/2006 | US7030086 Stabilized liquid polypeptide-containing pharmaceutical compositions |
| 04/18/2006 | US7029914 DNA encoding SNORF36 receptors |
| 04/18/2006 | US7029898 Comprises chimeric polypeptide with hydrolase and mitogen activated protein kinase activity for diagnosis and treatment of cell proliferation and differentiation disorders |
| 04/18/2006 | US7029894 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 04/18/2006 | US7029877 binding protease thrombin to phosphoethanolamine binding protein |
| 04/18/2006 | US7029713 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising the same |
| 04/18/2006 | US7029696 Delivery and activation through liposome incorporation of diaminocyclohexane platinum(II) complexes |
| 04/18/2006 | US7029688 Methods and compositions to prevent formation of adhesions in biological tissues |
| 04/18/2006 | US7029664 Chicken leukemia inhibitory factor (LIF) |
| 04/18/2006 | US7029652 Administering dose of antiangiogenic cyclo-arginine-glycine-aspartic acid- containing pentapeptide (cRGD pentapeptide), radioimmunotherapeutic agent (RIT), and one additional dose of cRGD pentapeptide |
| 04/18/2006 | CA2346335C Sertraline oral concentrate |
| 04/18/2006 | CA2273374C Trioxane dimer compounds having antiproliferative and antitumor activities |
| 04/13/2006 | WO2006039569A1 Combination therapy of hedgehog inhibitors, radiation and chemotherapeutic agents |
| 04/13/2006 | WO2006039527A1 Macrocyclic sh2 domain binding inhibitors |
| 04/13/2006 | WO2006038989A1 Substituted arylamides |